Pharmafile Logo

Navigating the future of AI: Insights from EphMRA’s one day meeting in London

April 22, 2024 |  

Authored by: Ellie Forde and Mark Braund, Directors

- PMLiVE

The integration of Artificial Intelligence (AI) in the world of healthcare has opened new frontiers in medical research, patient care, and now in market research. Attending the 2024 UK One Day EphMRA meeting in London on this evolving topic provided thoughtful insights into how AI technologies are not just augmenting, but fundamentally starting to change in how we run healthcare market research. This summary delves into the key themes, innovations, and presentations from a range of experts in the field, offering a glimpse into the future of healthcare market research.

Read the full write up here.

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

PEGASUS AND UCL JOIN FORCES IN INSPIRING HEALTHY DECISIONS

Pegasus, an Ashfield company, part of UDG Healthcare plc, is proud to announce the launch of its new propriety model for planning in health – CHANGE – which was developed…

Cool heads in a crisis?

Understanding the role pharmaceutical companies can play in fighting today’s global health pandemics

Biosimilars: Bringing patients into the conversation

Published in eyeforpharma January 2017 by Mariel Metcalfe

Access and elimination: the future of DAAs in hepatitis C

Published in Pharmaphorum January 2017

EphMRA One Day Meeting

We are delighted to be attending and presenting a paper at the EphMRA one day meeting on Tuesday 21st February, in London

Video: Segmentation research

Why would a pharma company want to carry out a segmentation study? What are some of the challenges? Head of Business Analytics Tom Nolte and Associate Director Dr Marianne Jaeger…

Pharmaceutical Market Research Conference 2017

We are delighted to be exhibiting and presenting a paper at the Pharmaceutical Market Research Conference 1-2 February in Parsippany, NJ.

Shifting perceptions of the use of probiotics in IBS Management

Our client was planning to launch an over-the-counter (OTC) probiotics product for the purposes of improving IBS management and wanted to understand current perceptions, practices and usage amoungst a range…

Nutraceuticals in India: A Challenging Opportunity

Published in eyeforpharma December 2016 by Marc Yates

Research Partnership makes annual donation to Forever Projects

Research Partnership has made a seasonal donation of US$5,000 to our chosen charity, Forever Projects